<code id='D12EDB609D'></code><style id='D12EDB609D'></style>
    • <acronym id='D12EDB609D'></acronym>
      <center id='D12EDB609D'><center id='D12EDB609D'><tfoot id='D12EDB609D'></tfoot></center><abbr id='D12EDB609D'><dir id='D12EDB609D'><tfoot id='D12EDB609D'></tfoot><noframes id='D12EDB609D'>

    • <optgroup id='D12EDB609D'><strike id='D12EDB609D'><sup id='D12EDB609D'></sup></strike><code id='D12EDB609D'></code></optgroup>
        1. <b id='D12EDB609D'><label id='D12EDB609D'><select id='D12EDB609D'><dt id='D12EDB609D'><span id='D12EDB609D'></span></dt></select></label></b><u id='D12EDB609D'></u>
          <i id='D12EDB609D'><strike id='D12EDB609D'><tt id='D12EDB609D'><pre id='D12EDB609D'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:44
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          UCB departs biotech trade group BIO
          UCB departs biotech trade group BIO

          AdobeWASHINGTON— UCBleftBIOattheendof2023,thesecondmajormembercompanytoexitafterPfizerpulledoutaswel

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          New weight loss drugs work. But how can they best be used?

          SteffenTrumpf/picturealliance/GettyImagesLONDON—Startinginthenewyear,ateamofresearchersintheU.K.andD